These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9028413)

  • 1. Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel--an interim report.
    Richter J; Poggensee G; Kjetland EF; Helling-Giese G; Chitsulo L; Kumwenda N; Gundersen SG; Deelder AM; Reimert CM; Haas H; Krantz I; Feldmeier H
    Acta Trop; 1996 Dec; 62(4):289-301. PubMed ID: 9028413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female genital schistosomiasis due to Schistosoma haematobium. Clinical and parasitological findings in women in rural Malawi.
    Kjetland EF; Poggensee G; Helling-Giese G; Richter J; Sjaastad A; Chitsulo L; Kumwenda N; Gundersen SG; Krantz I; Feldmeier H
    Acta Trop; 1996 Dec; 62(4):239-55. PubMed ID: 9028409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of female genital schistosomiasis by indirect disease markers: determination of eosinophil cationic protein, neopterin and IgA in vaginal fluid and swab eluates.
    Poggensee G; Reimert CM; Nilsson LA; Jamaly S; Sjastad A; Roald B; Kjetland EF; Helling-Giese G; Richter J; Chitsulo L; Kumwenda N; Gundersen SG; Krantz I; Feldmeier H
    Acta Trop; 1996 Dec; 62(4):269-80. PubMed ID: 9028411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area.
    Midzi N; Ndhlovu PD; Nyanga L; Kjetland EF; Reimert CM; Vennervald BJ; Gomo E; Mudenge G; Friis H; Gundersen SG; Mduluza T
    Parasite Immunol; 2003; 25(11-12):581-8. PubMed ID: 15053779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine reagent strips for diagnosis of schistosomiasis haematobium in women of fertile age.
    Gundersen SG; Kjetland EF; Poggensee G; Helling-Giese G; Richter J; Chitsulo L; Koumwenda N; Krantz I; Feldmeier H
    Acta Trop; 1996 Dec; 62(4):281-7. PubMed ID: 9028412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female genital schistosomiasis (FGS): relationship between gynecological and histopathological findings.
    Helling-Giese G; Sjaastad A; Poggensee G; Kjetland EF; Richter J; Chitsulo L; Kumwenda N; Racz P; Roald B; Gundersen SG; Krantz I; Feldmeier H
    Acta Trop; 1996 Dec; 62(4):257-67. PubMed ID: 9028410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cure by detection of circulating antigens in serum and urine, following schistosomiasis mass treatment in two villages of the Office du Niger, Mali.
    De Clercq D; Sacko M; Vercruysse J; vanden Bussche V; Landouré A; Diarra A; Gryseels B; Deelder A
    Acta Trop; 1997 Dec; 68(3):339-46. PubMed ID: 9492918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women.
    Kjetland EF; Ndhlovu PD; Mduluza T; Gomo E; Gwanzura L; Mason PR; Kurewa EN; Midzi N; Friis H; Gundersen SG
    Am J Trop Med Hyg; 2005 Mar; 72(3):311-9. PubMed ID: 15772328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genital schistosomiasis--diagnosis and therapy].
    Elling D; Kupferschmidt HG
    Zentralbl Gynakol; 1988; 110(11):671-6. PubMed ID: 3137734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors for participation in mass-treatment and female genital schistosomiasis re-investigation, and the effect of praziquantel treatment in South African adolescents.
    Nemungadi TG; Kleppa E; Galappaththi-Arachchige HN; Pillay P; Gundersen SG; Vennervald BJ; Ndhlovu PD; Taylor M; Naidoo S; Kjetland EF
    PLoS Negl Trop Dis; 2024 Mar; 18(3):e0011798. PubMed ID: 38536861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment.
    Kjetland EF; Ndhlovu PD; Kurewa EN; Midzi N; Gomo E; Mduluza T; Friis H; Gundersen SG
    Am J Trop Med Hyg; 2008 Jul; 79(1):79-83. PubMed ID: 18606767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, observational study to assess the performance of CAA measurement as a diagnostic tool for the detection of Schistosoma haematobium infections in pregnant women and their child in Lambaréné, Gabon: study protocol of the freeBILy clinical trial in Gabon.
    Honkpehedji YJ; Adegnika AA; Dejon-Agobe JC; Zinsou JF; Mba RB; Gerstenberg J; Rakotozandrindrainy R; Rakotoarivelo RA; Rasamoelina T; Sicuri E; Schwarz NG; Corstjens PLAM; Hoekstra PT; van Dam GJ; Kreidenweiss A;
    BMC Infect Dis; 2020 Sep; 20(1):718. PubMed ID: 32993559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cure in schistosomiasis patients after chemotherapy with praziquantel by quantitation of circulating anodic antigen (CAA) in urine.
    van Lieshout L; de Jonge N; Bassily S; Mansour MM; Deelder AM
    Am J Trop Med Hyg; 1991 Mar; 44(3):323-8. PubMed ID: 1903605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating antigens in patients with active Schistosoma haematobium infection.
    Hassan MM; Medhat A; Makhlouf MM; Shata T; Nafeh MA; Osman OA; Deaf EA; Galal N; Fouad YM
    Am J Trop Med Hyg; 1998 Aug; 59(2):295-301. PubMed ID: 9715950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
    Barda B; Coulibaly JT; Hatz C; Keiser J
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic and operational profiles of metrifonate and praziquantel in Schistosoma haematobium infection.
    Feldmeier H; Chitsulo L
    Arzneimittelforschung; 1999 Jul; 49(7):557-65. PubMed ID: 10442201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel.
    Kjetland EF; Mduluza T; Ndhlovu PD; Gomo E; Gwanzura L; Midzi N; Mason PR; Friis H; Gundersen SG
    Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):740-52. PubMed ID: 16406034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day-to-day variation of egg output and schistosome circulating antigens in urine of Schistosoma haematobium-infected school children from Gabon and follow-up after chemotherapy.
    Van Etten L; Kremsner PG; Krijger FW; Deelder AM
    Am J Trop Med Hyg; 1997 Sep; 57(3):337-41. PubMed ID: 9311646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.